Data as of May 17
| -1.14 / -0.50%|
The 22 analysts offering 12-month price forecasts for Biogen Idec Inc have a median target of 226.50, with a high estimate of 270.00 and a low estimate of 158.51. The median estimate represents a -0.15% decrease from the last price of 226.85.
The current consensus among 30 polled investment analysts is to Buy stock in Biogen Idec Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.